Idefirix האיחוד האירופי - סלובנית - EMA (European Medicines Agency)

idefirix

hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - imunosupresivi - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.

Vyvgart האיחוד האירופי - סלובנית - EMA (European Medicines Agency)

vyvgart

argenx - efgartigimod alfa - myasthenia gravis - imunosupresivi - vyvgart is indicated as an add on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gmg) who are anti acetylcholine receptor (achr) antibody positive.

Odomzo האיחוד האירופי - סלובנית - EMA (European Medicines Agency)

odomzo

sun pharmaceutical industries europe b.v. - sonidegib difosfat - karcinom, bazalna celica - antineoplastična sredstva - odomzo je indiciran za zdravljenje odraslih bolnikov z lokalno napredovalim karcinomom bazalnih celic (bcc), ki niso primerni za kurativno kirurgijo ali radioterapijo.